Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis

被引:126
|
作者
Sabatino, A. [1 ]
Regolisti, G. [1 ]
Karupaiah, T. [2 ]
Sahathevan, S. [2 ]
Singh, B. K. Sadu [2 ]
Khor, B. H. [2 ]
Salhab, N. [3 ]
Karavetian, M. [4 ]
Cupisti, A. [5 ]
Fiaccadori, E. [1 ]
机构
[1] Univ Parma, Dept Clin & Expt Med, Acute & Chron Renal Failure Unit, Parma, Italy
[2] Natl Univ Malaysia, Fac Hlth Sci, Dietet Program, Kuala Lumpur, Malaysia
[3] Maastricht Univ, Dept Nutr & Translat Res Metab, Maastricht, Netherlands
[4] Zayed Univ, Dept Nat Sci Publ Hlth, Dubai, U Arab Emirates
[5] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
关键词
Chronic kidney disease; Hemodialysis; Nutrients; Nutritional status; Protein-energy wasting; CHRONIC KIDNEY-DISEASE; INTRADIALYTIC PARENTERAL-NUTRITION; MAINTENANCE HEMODIALYSIS; BODY-COMPOSITION; METABOLIC-ACIDOSIS; PHYSICAL-ACTIVITY; DIALYSIS PATIENTS; GUT MICROBIOME; OMEGA-3-FATTY-ACIDS; MORTALITY;
D O I
10.1016/j.clnu.2016.06.007
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Protein -Energy Wasting (PEW) is the depletion of protein/energy stores observed in the most advanced stages of Chronic Kidney Disease (CKD). PEW is highly prevalent among patients on chronic dialysis, and is associated with adverse clinical outcomes, high morbidity/mortality rates and increased healthcare costs. This narrative review was aimed at exploring the pathophysiology of PEW in end-stage renal disease (ESRD) on hemodialysis. The main aspects of nutritional status evaluation, intervention and monitoring in this clinical setting were described, as well as the current approaches for the prevention and treatment of ESRD-related PEW. Methods: An exhaustive literature search was performed, in order to identify the relevant studies describing the epidemiology, pathogenesis, nutritional intervention and outcome of PEW in ESRD on hemodialysis. Results and conclusion: The pathogenesis of PEW is multifactorial. Loss of appetite, reduced intake of nutrients and altered lean body mass anabolism/catabolism play a key role. Nutritional approach to PEW should be based on a careful and periodic assessment of nutritional status and on timely dietary counseling. When protein and energy intakes are reduced, nutritional supplementation by means of specific oral formulations administered during the hemodialysis session may be the first-step intervention, and represents a valid nutritional approach to PEW prevention and treatment since it is easy, effective and safe. Omega-3 fatty acids and fibers, now included in commercially-available preparations for renal patients, could lend relevant added value to macronutrient supplementation. When oral supplementation fails, intradialytic parenteral nutrition can be implemented in selected patients. (C) 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:663 / 671
页数:9
相关论文
共 50 条
  • [21] L-Carnitine Supplementation and Adipokines in Patients with End-Stage Renal Disease on Regular Hemodialysis
    Csiky, B.
    Nyul, Z.
    Toth, G.
    Wittmann, I.
    Melegh, B.
    Rauh, M.
    Rascher, W.
    Sulyok, E.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (10) : 735 - 740
  • [22] Association of Depression With Selenium Deficiency and Nutritional Markers in the Patients With End-Stage Renal Disease on Hemodialysis
    Ekramzadeh, Maryam
    Mazloom, Zohreh
    Sagheb, Mohammadmahdi
    JOURNAL OF RENAL NUTRITION, 2015, 25 (04) : 381 - 387
  • [23] The association between thyroid function and nutritional status in patients with end-stage renal disease on hemodialysis
    Shehab-Eldin, Walid
    Shaaban, Mohamed Ahmed
    Atia, Mai Abdel Samed
    Zewain, Shimaa Kamal
    ALEXANDRIA JOURNAL OF MEDICINE, 2020, 56 (01) : 220 - 225
  • [24] Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis
    Cotoi, Laura
    Borcan, Florin
    Sporea, Ioan
    Amzar, Daniela
    Schiller, Oana
    Schiller, Adalbert
    Dehelean, Cristina A.
    Pop, Gheorghe Nicusor
    Borlea, Andreea
    Stoian, Dana
    DIAGNOSTICS, 2020, 10 (04)
  • [25] Cutaneous manifestations in patients with end-stage renal disease on hemodialysis
    Kebria, Azar Shirzadian
    Aryanian, Zeinab
    Choobdar, Amin
    Akbari, Roghayeh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (04) : 728 - 731
  • [26] Reticulocyte markers in patients with end-stage renal disease on hemodialysis
    Bhandari, S
    Turney, JH
    Brownjohn, AM
    KIDNEY INTERNATIONAL, 1997, 52 (01) : 273 - 274
  • [27] Depression among patients with end-stage renal disease in hemodialysis
    Silva Junior, Geraldo B.
    Daher, Elizabeth F.
    Buosi, Ana Paula A.
    Lima, Rafael S. A.
    Lima, Mikaelly M.
    Silva, Eveline C.
    Sampaio, Aline M.
    Santana, Joao Moises L.
    Monteiro, Francisco Emmanuel C.
    Araujo, Snia M. H. A.
    PSYCHOLOGY HEALTH & MEDICINE, 2014, 19 (05) : 547 - 551
  • [28] Evaluation of proBNP in End-stage Renal Disease Patients on Hemodialysis
    Nakagawa, Yasuaki
    Nishikimi, Toshio
    Kuwahara, Koichiro
    Yasuno, Shinji
    Kinoshita, Hideyuki
    Kuwabara, Yoshihiro
    Nakao, Kazuhiro
    Yamada, Chinatsu
    Ueshima, Kenji
    Nakao, Kazuwa
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S168 - S168
  • [29] Sleep disturbances in end-stage renal disease patients on hemodialysis
    Veiga, J
    Goncalves, N
    Gomes, F
    Santos, N
    Baptista, A
    Paiva, T
    DIALYSIS & TRANSPLANTATION, 1997, 26 (06) : 380 - &
  • [30] Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis
    Alves Rios, Danyelle Romana
    Pinheiro, Melina Barros
    de Oliveira Junior, Wander Valadares
    Gomes, Karina Braga
    Carvalho, Andrea Teixeira
    Martins-Filho, Olindo Assis
    Simoes e Silva, Ana Cristina
    Sant'Ana Dusse, Luci Maria
    DISEASE MARKERS, 2017, 2017